Category

Product Liability

UK Women Call for Transvaginal Tape Surgery Ban

By | Product Liability, Transvaginal Mesh, Uncategorized

transvaginal_mesh_mdl_2013_settlements_side_effects_court_filing_lawsuitsHundreds of women in the United Kingdom are demanding that Transvaginal Tape (TVT) operations be suspended.

These women have been devastated by a variety of disorders from chronic pain to the inability to walk, resulting from the procedure to stop stress incontinence. They weren’t made aware of the potential life changing risks from the surgery.

Kath Sansom had the operation, involving the implant of an artificial mesh tape to support the bladder. Now the mother-of-two wishes she had never attempted to fix the minor problem.

Ms. Ransom was a self-described fitness junkie, participating in boxing, swimming and high diving before the surgery. Now she’s lucky if she can walk for 15 minutes before she gets dizzy and develops intense pain.

She launched the Sling the Mesh campaign, calling for TVT surgery to be suspended and for the government to create stricter policies for approving medical devices. She got the campaign idea from a neighboring country: Scotland placed a ban on the surgery in 2014.

In England approximately 13,000 women have TVT surgery every year. Officially, in 2010, 603 TVT surgeries were reversed. However only 15 adverse incident reports were made to the Medicines and Healthcare Products Regulatory Agency (MHRA).

Many women don’t know where to report their grievances. Kath Sansom intends to change that by calling attention to the problem with her campaign.

Carey Danis & Lowe Attorneys Can Help

The St. Louis personal injury attorneys at Carey Danis & Lowe are experts on transvaginal tape cases and are providing free legal evaluations. If you or someone you know has been harmed by transvaginal mesh products, please tell us about your case.

If you have questions about transvaginal mesh and the accompanying health complications, ask questions of our on-staff medical experts. Our team is here to support you with professional legal and medical advice.

U.S. Farmers Suffer $1 Billion in Losses from Disrupted Corn Trade with China

By | Consumer protection, GMO, Product Liability, Uncategorized

gI_118526_cdl-pr-122014-gmo-corn-seed-lawsuitsIowa farmers continue to suffer financial losses as a result of China’s import ban on Syngenta GMO corn. Though China began accepting U.S.-grown GMO corn products in December 2014, the farming industry continues to feel the impact of the trade disruption.

According to The Gazette, an Iowa newspaper, China is no longer the top importer of U.S. corn products, since the country banned imports of GMO corn products grown using a corn seed developed by Syngenta.

Also, one Iowa farmer was quoted by the Iowa newspaper as saying that the drop in corn prices is related to disrupted trade with China.

Without a stable foreign market to sell to, a drop in corn prices was inevitable.

The per bushel price of corn fell considerably from July to October 2013, from $6.79 per bushel to $4.63.

The Gazette article mentioned that financial losses suffered by U.S. farmers as a result of the decline in the per bushel price could be around $1 billion. This estimate comes from the National Grain and Feed Association.

Iowa farmers, and U.S. corn growers across the U.S., continue to be impacted by China’s import ban on Syngenta GMO corn. With the growing season ramping up, many are hoping for a better year.

Carey Danis & Lowe represents U.S. corn farmers.

Carey Danis & Lowe is a St. Louis law firm that currently represents U.S. corn farmers who have suffered financial losses as a result of GMO corn. Our team of experienced corn lawyers work tirelessly for our clients to recover any and all losses.

If you are a U.S. corn farmer or exporter who took a financial hit as a result of GMO corn―whether through the Syngenta ban or through cross-pollination―we can help you. Our law firm offers free case evaluations, during which we guide you through your legal options and compensation eligibility. And if appropriate, we can help you file a GMO corn seed lawsuit.

Contact Carey Danis & Lowe today for your free case evaluation. You can reach our law offices by phone at 800.721.2519, or by completing a confidential claim form.

GMO Corn Lawsuits Spurred by Foreign Market Refusals

By | Consumer protection, GMO, Product Liability, Uncategorized

gmo_corn_class_action_lawsuitWhat does China have to do with people growing and distributing corn in the US?

A lot, in fact.

China’s refusal to import US corn products containing a genetically modified trait brought financial troubles to farmers in the US.

US corn growers planted their corn crop using a GMO corn seed developed by a Swiss biotech giant, Syngenta. The GMO seed, called Agrisure Viptera, or MIR 162, came onto the US market in 2010. However, unbeknownst to US corn growers, China―a major trading partner―hadn’t given Syngenta’s new GMO corn seed the stamp of approval.

China Refuses to Import Agrisure Viptera Corn Products

After China rejected corn products containing Agrisure Viptera, US corn growers had no where to turn next, so they soon became burdened with lost income.

Sygenta & Approval from Foreign Markets

Syngenta never sought approval from China before bringing their GMO corn seed to the US market.

As a result, US corn growers have filed GMO corn lawsuits targeting Sygenta for lost income and neglecting to recognize the importance of the trade partnership between the US and China.

According to experts quoted in an article by Capital Press, an agricultural news service, foreign markets, like China, could play a future role in GMO product regulation, especially in regards to exports.

The Capital Press article also noted that the situation with Syngenta and GMO corn seed lawsuits may prevent other biotech companies from introducing new products onto the market for fear of litigation.

Legal Assistance for US Corn Farmers

Carey Danis & Lowe is currently investigating GMO corn seed cases involving US corn farmers who suffered financially. If you experienced lost income as a result of GMO corn seeds, we encourage you to begin exploring your legal options.

Our law firm offers free legal evaluations. During our evaluations, one of our lawyers guides you through your legal options and compensation eligibility.

Contact Carey Danis & Lowe today by phone at 800.721.2519, or complete a confidential claim form.

Want to learn more about GMO corn seed lawsuits? You might be interested in reading:

GMO Corn Seed Lawsuit Filed by Kentucky Farm

By | Consumer protection, GMO, Product Liability, Uncategorized

gmocornseedlawsuitA Kentucky farm filed a GMO corn seed lawsuit against Syngenta. A Swiss biotech giant, Syngenta is the target of late in many GMO corn lawsuits, since the company brought to market a GMO corn seed―Agrisure Viptera, or MIR 162―without winning approval from a major U.S. trading partner, China.

According to the legal news website, Top Class Actions, the Kentucky farm, Moss Farms, didn’t directly grow corn using Syngenta MIR 162 seeds; rather, nearby farms growing corn from MIR 162 seeds most likely contaminated the corn crop of Moss Farms through cross-pollination.

Unfortunately, for many U.S. corn growers and distributors, cross-pollination of non-GMO corn―or GMO corn approved for import in China and other trading partners―has led to serious financial loss.

Did Your Finances Get Hit by Syngenta MIR 162 Corn Seeds?

If you have experienced financial losses resulting from cross-pollination with MIR 162 corn, we encourage you to explore your legal options now.

Carey Danis & Lowe is currently investigating GMO corn seed lawsuits, and is offering free case evaluations. During our case evaluations, we guide you through your compensation eligibility, and how to file a GMO corn lawsuit.

We Can Help You

Contact our law firm today by calling 800.721.2519, or complete a confidential claim form. We look forward to offering you any assistance that we can.

Continue to read the Carey Danis & Lowe law blog to stay current on GMO corn seed lawsuit updates.

You may be interested in reading:

 

 

J&J Abandons Vaginal Mesh Lawsuit Fraud Investigation

By | Class Action, Consumer protection, GMO, Product Liability, Uncategorized

vaginal_mesh_lawsuits_settlementsThe team of defective medical device lawyers at Carey Danis & Lowe recently reported on our law blog that Johnson & Johnson filed a motion in a West Virginia federal court requesting an investigation into the validity of vaginal mesh lawsuits. What influenced the mesh manufacturer’s decision was communication they had with women who claimed that phone solicitors called them about filing a vaginal mesh lawsuit.

According to Reuters, these women told Johnson & Johnson that the phone solicitors asked the women about whether or not they received a transvaginal mesh implant. Also, the phone solicitors mentioned how filing a transvaginal mesh lawsuit could result in $40,000 in compensation.

Johnson & Johnson asserted that these phone solicitors could have played a major role in the tens of thousands of lawsuits targeted at Johnson & Johnson and their subsidiary, Ethicon.

Even though Johnson & Johnson appeared resolute in investigating each case’s validity, this is no longer true. According to a court filing, Johnson & Johnson recently abandoned their fraud investigation. However, the motivations behind this abandonment are unknown.

Carey Danis & Lowe believes that Johnson & Johnson’s decision is a sound one. With the mesh manufacturer facing approximately 35,000 vaginal mesh lawsuits, sifting through each case to determine its validity would have a detrimental effect on an efficient legal process.

We Represent Mesh Victims

Carey Danis & Lowe provides our expert legal services to people like you who suffer from transvaginal mesh complications.

If you suffer from injuries related to a transvaginal mesh implant, we encourage you to review your legal options with us today. One of our personal injury lawyers can also evaluate your compensation eligibility. We offer free, no obligation case consultations.

Share your story with Carey Danis & Lowe. Call us at 800.721.2519, or complete a confidential personal injury claim form.

800 GMO Corn Lawsuits from 20 States

By | Consumer protection, GMO, Product Liability, Uncategorized

gmocornseedlawsuitU.S. corn growers are taking a stand against biotechnology companies by filing GMO corn lawsuits. There are approximately 800 pending lawsuits from 20 states. In late January, a judicial panel ruled to consolidate a portion of these lawsuits into a multidistrict litigation (MDL) under the management of Judge John Lungstrum in a U.S. District Court in Kansas.

The farmers behind these 800 GMO corn lawsuits claim to have suffered financial losses somewhere between $1 – $2.9 billion.

According to Arkansas Business, farmers growing non-GMO corn have also suffered financially as a result of cross-pollination.

These GMO corn seed lawsuits concern a genetically-modified corn seed developed by a Swiss biotechnology company, Syngenta. The GMO corn seed is Agrisure Viptera, or MIR 162.

Though China now accepts imports of corn products grown by using Agrisure Viptera seeds, this was not always the case. A major trade partner, China’s refusal of Agrisure Viptera corn products caused substantial financial damage to U.S. corn growers.

Losses from GMO Corn?

If you suffered losses from GMO corn, we can help. Carey Danis & Lowe is a St. Louis-based law firm that currently represents farmers in GMO corn lawsuits in Missouri and other corn-growing states. Our dedicated team of attorneys work diligently to recover losses for clients.

We encourage you to begin exploring your legal options and compensation eligibility today. Carey Danis & Lowe offers free, no obligation case evaluations. Find out if you should file a GMO corn lawsuit.

Contact Carey Danis & Lowe today by calling 800.721.2519, or by completing a confidential claim form.

Mirena IUD Injuries Include Migration & Perforation

By | Defective Medical Device litigation, Pharmaceutical litigation, Product Liability, Uncategorized

mirena_iud_lawsuit_settlements_class_action_lawsuit_mirena_mdlThe Mirena intrauterine device (IUD) has been known to become dislodged and migrate to another part of the body, and as a result, cause serious internal damage. One woman who used the Mirena IUD experienced just such a thing, and underwent more than four surgical operations to remove and repair damage caused by Mirena IUD migration. Her story was recently chronicled in an article by Newsweek.

This woman, who in the article is referred to as “K.”, received the Mirena IUD following a pregnancy. After implantation, the contraceptive device perforated her uterine wall, and migrated to her abdominal area.

Due to the injuries that she incurred from the Mirena IUD, as well as the numerous surgical operations that she underwent as a result of device perforation and migration, K. filed a lawsuit targeted at Bayer.

According to the Newsweek article, Bayer faces over 1,200 Mirena lawsuits in the U.S.

Carey Danis & Lowe Can Help You

Women injured by Bayer’s device link the Mirena IUD to device perforation, migration, ectopic pregnancy, pelvic inflammatory disease, and infertility. The defective medical device lawyers at Carey Danis & Lowe, a national law firm with headquarters in St. Louis, represent women injured in Mirena IUD lawsuits.

Carey Danis & Lowe is currently investigating Mirena IUD cases, and encourages women who sustained injuries after using the Mirena IUD to explore their legal options and compensation eligibility. Carey Danis & Lowe offers free initial case evaluations.

Share your Mirena IUD story with us today. Contact Carey Danis & Lowe by phone at 800.721.2519, or by completing our personal injury claim form.

FDA Presents New Transvaginal Mesh Orders

By | Defective Medical Device litigation, Product Liability, Transvaginal Mesh, Uncategorized

fdaThe U.S. Food & Drug Administration (FDA) announced in a news release dated April 29, 2014 that it would put forth two orders relating to transvaginal mesh used to treat women with pelvic organ prolapse (POP). The two orders have not been made final, and the FDA is accepting feedback on their propositions over a three month period.

One of the orders recommends updating the classification of transvaginal mesh for POP so that it accurately reflects the health risks caused by these medical devices. In their April news release, the FDA advises that transvaginal mesh be classified as class III, meaning that it is a high-risk device. The FDA currently classifies transvaginal mesh for POP as a class II device, which denotes that the device poses a moderate risk to the patient’s health and safety.

A number of the transvaginal mesh products that have been sold in the U.S. were brought to market using an expedited FDA approval process known as the 510(k) application. Medical device manufacturers, such as Johnson & Johnson and their subsidiary Ethicon, use the 510(k) process to introduce new products onto the market that are updated versions of an FDA approved device. In some cases, due to similarities between two products, companies do not submit extensive safety information.

Now that transvaginal mesh injuries have become evident, the FDA proposes that any new transvaginal mesh products seeking approval to treat POP must submit a premarket approval application. This application would require manufacturers to collect and submit thorough data about the new product from a premarket clinical trial.

Carey Danis & Lowe Represents Victims

Transvaginal mesh injuries can be life-changing. Our attorneys recognize the pain and suffering endured by women and families impacted by transvaginal mesh.

The defective medical device lawyers at Carey Danis & Lowe represent individuals and families who have been negatively impacted by certain medical devices, including transvaginal mesh. We are currently investigating transvaginal mesh cases. If you have been injured by mesh, Carey Danis & Lowe encourages you to begin exploring your legal options and compensation eligibility. We offer free initial case evaluations.

Share your transvaginal mesh story with Carey Danis & Lowe today by calling 800.721.2519, or by completing one of our personal injury claim forms.

FDA 510(k) Approval Process & Patient Safety (Transvaginal Mesh)

By | Defective Medical Device litigation, Product Liability, Transvaginal Mesh, Uncategorized

fdaThough the 510(k) approval process used by the U.S. Food & Drug Administration (FDA) to quickly and efficiently clear medical devices similar to already approved products has its benefits, the process does present hazards to patient health and safety, since it is less stringent about clinical trials. For example, if a medical device manufacturer already received FDA approval for a certain product, some companies have been known to redesign that original product in a small way, and bypass the requirement of conducting clinical trials, since the new, slightly modified product is considered similar to the original product.

This process of winning approval without proof of consumer safety is the topic of a recently published article on the New York Times Well blog. As discussed in the article, after gaining FDA approval, a medical device manufacturer can alter their product for what appears to be an unlimited number of times without having to reapply for approval.

Over time, accounting for all of the modifications, it is highly likely that the original product would no longer be similar to the modified product. In such a case as this, a clinical trial is imperative in gaining a better understanding of whether the modified product is still as safe to use as the original.

Through submitting their modified transvaginal mesh products through the 510(k) approval process, Johnson & Johnson (J&J) was able to send to market a number of products that have since been the subject of thousands of lawsuits filed across the U.S.

J&J submitted a 510(k) application for the Gynecare Prolift mesh, and received approval in May 2008. According to a Bloomberg article published in March 2012, the FDA cleared the Prolift mesh because, in their 510(k) application, J&J supplied evidence that the Prolift was as safe to use as the original mesh product, Gynemesh.

Though the evidence said otherwise, the Gynecare Prolift mesh has been blamed for debilitating injuries sustained by thousands of women due to mesh erosion. For some women, these transvaginal mesh injuries have permanently changed their lives.

Carey Danis & Lowe Can Help

Carey Danis & Lowe is a national law firm based in St. Louis that has a team of dedicated defective medical device lawyers who represent women who have been injured by transvaginal mesh. If you have been injured by transvaginal mesh, explore your legal options and compensation eligibility with Carey Danis & Lowe today.

Contact Carey Danis & Lowe by phone at 800.721.2519, or by completing one of our confidential personal injury claim forms.

$4 Billion DePuy ASR Hip Settlement in the Works

By | Defective Medical Device litigation, Hip/Knee Replacement, Product Liability, Uncategorized

DePuy ASR Hip Replacement Lawsuit Update: Trials Scheduled to Begin this Year in Maryland, New Jersey, and OhioClaims targeted at DePuy, a unit of Johnson & Johnson, over their ASR hip implant may soon be settled following the announcement of a $4 billion agreement intended to settle approximately 7,500 DePuy ASR hip lawsuits in state and federal courts across the country. According to Bloomberg, plaintiffs have filed lawsuits against DePuy and Johnson & Johnson claiming that their ASR hip implant was defectively designed, compromised health, and required numerous revision surgeries.

It is estimated that each plaintiff will receive a compensation package of around $300,000 for each of their surgical operations, though this could change depending upon a plaintiff’s age and other factors, such as the severity of injuries incurred from the ASR hip implant.

Approximately 12,000 lawsuits are pending in state courts in California, New Jersey, and Illinois. In Toledo, Ohio, DePuy ASR hip lawsuits have been consolidated into a multidistrict litigation (MDL) called In re: DePuy Orthopedics, Inc., ASR Hip Implant Products Liability Litigation, MDL no. 2197, which is being heard in the U.S. District Court for the Northern District of Ohio.

DePuy ASR Hip Implant History

In 2005, DePuy began selling their ASR hip implant in the U.S. Five years later, in August 2010, the metal-on-metal hip implant was recalled due to its high failure rate. DePuy removed approximately 93,000 hip implants from the market in the U.S. and around the world.

To explain their reason for the recall, DePuy pointed to a UK study whose data revealed a 12 – 13 percent failure rate for the ASR XL Acetabular System and the ASR Hip Resurfacing System, a model sold outside the U.S. that was never approved by the U.S. Food and Drug Administration (FDA) due reports that it released excessive amounts of metal particles.

Though the UK study reported an abnormally high failure rate, it appears that Johnson & Johnson and DePuy had gathered their own data that showed an even higher failure rate at 37 percent within 4.6 years. Additionally, the New York Times reported that two years before the DePuy ASR hip recall, a DePuy consultant notified the head of the DePuy orthopedic unit about the ASR hip implant’s defective design.

Thus, there were a number of warning signs alerting DePuy and Johnson & Johnson as to the flawed nature of their ASR metal-on-metal hip implant.

Future of DePuy ASR Hip Lawsuits

Though the current settlement amount is estimated to be around $4 billion, sources say this number could increase as patients continue to develop problems with the defective medical device in the near future, and require revision and replacement surgeries.

As it stands, DePuy’s agreement appears to contain nothing that could potentially hinder patients from trying to obtain a compensation package from DePuy and Johnson & Johnson to cover medical expenses.

This means that, at the current moment, the settlement has no limit.

How Carey Danis & Lowe Can Help You

The defective medical device lawyers at Carey Danis & Lowe are encouraged by the news of the $4 billion DePuy ASR hip settlement. As a law firm that represents victims of the DePuy ASR hip implant, Carey Danis & Lowe hopes that case resolution following this settlement is swift and efficient, as so many people have claimed pain, suffering, and injury from this defective medical device.

If you believe that you have incurred injuries from the DePuy ASR hip implant, contact a defective medical device lawyer at Carey Danis & Lowe to discuss your legal options and for assistance with filing a DePuy ASR hip lawsuit. When contacting our St. Louis based law firm, you can also speak with one of our on-staff nurses about metal-on-metal hip implant safety concerns.

Share your DePuy ASR hip implant story with Carey Danis & Lowe today by calling 800.721.2519, or by submitting a confidential personal injury claim.

Learn more about the DePuy ASR hip and personal injury litigation on the Carey Danis & Lowe blog. Stay current on the latest defective medical device news, such as the recent metal-on-metal hip implants ban in UK hospitals.